Altered tear fluid protein expression in persons with mild Alzheimer's disease in proteins involved in oxidative stress, protein synthesis, and energy metabolism
Open Access
- 4 April 2025
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 105 (1) , 292-301
Abstract
Background: Tear fluid (TF) is a protein-rich solution that reflects pathophysiological changes in Alzheimer's disease (AD). Objective: In this study, we examined whether TF proteins were differently expressed in persons with mild AD dementia compared to cognitively healthy controls (CO). Methods: We analyzed data from 53 study participants including 34 CO (mean age, 71 years; Mini-Mental State Examination [MMSE] score, 28.9 ± 1.4), and 19 patients with AD (Clinical Dementia Rating, 0.5–1; mean age, 72 years; MMSE score, 23.8 ± 2.8). All participants underwent cognitive testing, as well as neurological and ophthalmological examinations. TF was collected using Schirmer strips, and TF protein content was evaluated using mass spectrometry-based proteomics and label-free quantification. Results: We found that 16 proteins exhibited significantly upregulated expression in the AD group compared to the CO group ( p ≤ 0.05). These proteins were NP1L4, BBOX1, CYTC, RNAS4, PCD, RNT2, AL1A3, SYSC, TPIS, CLH1, PGAM1, EIF3L, 5NTC, HNRNPA2B1, PYGL, and ERO1α. No proteins were significantly downregulated in the AD group compared to the CO group. Conclusions: Our results support the hypothesis that TF is a potential source of biomarkers for AD. Part of those proteins with altered expression have previously linked to increased oxidative stress, changed protein synthesis, and disturbed regulation of energy metabolism related to AD or neurodegenerative disease. The present results indicate the value of continued investigation of TF proteins in AD.Keywords
Funding Information
- Juho Vainion Säätiö
- Valtion tutkimusrahoitus
- Research council of Norway Infrastructur-program (295910)
This publication has 55 references indexed in Scilit:
- Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directionsAlzheimer's & Dementia, 2023
- Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stressFree Radical Biology and Medicine, 2022
- Brain arterial dilatation and the risk of Alzheimer's diseaseAlzheimer's & Dementia, 2019
- Corneal haze phenotype in Aldh3a1 -null mice: In vivo confocal microscopy and tissue imaging mass spectrometryChemico-Biological Interactions, 2017
- Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentAlzheimer's & Dementia, 2016
- Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stressAngiogenesis, 2012
- Aldehyde dehydrogenases and cell proliferationFree Radical Biology and Medicine, 2012
- Comparative studies of vertebrate aldehyde dehydrogenase 3: Sequences, structures, phylogeny and evolution. Evidence for a mammalian origin for the ALDH3A1 geneChemico-Biological Interactions, 2011
- The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseAlzheimer's & Dementia, 2011
- Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer DiseaseArchives of Neurology, 2000